🟠 Moderate Evidence
An economic model published in the Canadian Journal of Cardiology demonstrates that integrating pharmacists and nurse practitioners into heart failure medication management extends patient survival and reduces hospitalisation duration while lowering overall healthcare costs. The analysis projects substantial clinical and economic benefits for patients with one of the most common chronic conditions globally.
Key takeaways
- Pharmacist and nurse practitioner-led medication management improves outcomes for heart failure patients
- The expanded care model reduces hospitalisation length and hospital readmissions
- Cost-effectiveness analysis supports scaling this interprofessional approach across healthcare systems
Study at a Glance
| Source | Canadian Journal of Cardiology |
| Study type | Economic model / Cost-effectiveness analysis |
| Population | Patients with heart failure |
| Intervention | Pharmacist and nurse practitioner-led medication management |
| Outcomes measured | Patient survival, hospitalisation duration, cost-effectiveness |
Projected Benefits of Interprofessional Heart Failure Care
Clinical and economic outcomes from pharmacist and nurse practitioner-led medication management versus standard physician-only care
Source: Canadian Journal of Cardiology economic model, 2026 | Georgian Medical Journal News
Addressing gaps in heart failure management
Heart failure affects an estimated 64 million people globally, according to the American Heart Association. Medication management is a cornerstone of treatment, yet many patients struggle with adherence, complex regimens, and gaps in medication optimisation between routine clinic visits. The novel economic analysis in the Canadian Journal of Cardiology suggests that deploying pharmacists and nurse practitioners to lead medication management—under physician supervision—can bridge these critical care gaps.
Pharmacists bring specialised training in drug interactions, dosing, and adherence support. Nurse practitioners possess clinical assessment skills and can identify early signs of deterioration. Together, according to the model, these professionals can provide more frequent patient contact, optimise medications more rapidly, and reduce the burden on cardiologists managing large populations. This interprofessional approach has been successfully implemented in various clinical settings, though rigorous economic data at scale have been limited.
Expanding heart failure care to include pharmacist- and nurse practitioner-led medication management projects improved patient survival, reduced hospitalisation duration, and demonstrated cost-effectiveness compared to standard physician-only care.
— Canadian Journal of Cardiology economic model, 2026
Economic sustainability of the expanded model
Healthcare systems worldwide face pressure to improve outcomes while controlling costs. The Canadian Journal of Cardiology analysis provides economic evidence that interprofessional teams can achieve both simultaneously. By reducing hospital admissions and length of stay—two of the costliest components of heart failure care—the model demonstrates a financially sustainable pathway to scale this intervention across different jurisdictions and health systems.
This finding aligns with broader trends in healthcare delivery, where task-shifting to qualified non-physician providers has improved access and efficiency in chronic disease management. The analysis offers a quantifiable business case that policymakers and hospital administrators can use to justify investments in training and hiring pharmacists and nurse practitioners in heart failure programmes. The cost savings projected by the model suggest that initial staffing investments could be recovered within a defined timeframe.
Implications for clinical practice and policy
The Canadian Journal of Cardiology study provides a roadmap for healthcare organisations considering expansion of their heart failure programmes. Rather than relying solely on cardiologists and heart failure specialists—a labour shortage affecting most high-income and many middle-income countries—facilities can develop structured protocols for pharmacist and nurse practitioner roles in medication titration, patient education, and follow-up monitoring. Quality and safety standards are essential to ensure that task-shifting does not compromise care; the model assumes appropriate supervision, training, and communication protocols.
For healthcare policymakers, the findings suggest that regulatory frameworks supporting expanded scopes of practice for pharmacists and nurse practitioners in heart failure care warrant investment. Countries such as Canada, the United Kingdom, and Australia have already moved in this direction through legislative and regulatory changes. The economic evidence now supports this policy shift, potentially expediting adoption in other jurisdictions including Georgia.
What this means
Frequently asked questions
Can pharmacists and nurse practitioners safely manage heart failure medications without a cardiologist?
The economic model assumes appropriate physician oversight and structured protocols. Pharmacists and nurse practitioners do not replace cardiologists but rather work within a supervised interprofessional team, handling routine medication optimisation and monitoring under established guidelines and with clear escalation pathways for complex cases.
Which countries have already implemented pharmacist-led heart failure management?
Canada, Australia, the United Kingdom, and the United States have integrated pharmacists and nurse practitioners into heart failure programmes in selected centres. These real-world programmes provide evidence supporting the economic model published in the Canadian Journal of Cardiology, though outcomes vary based on local healthcare infrastructure and regulatory support.
What training do pharmacists and nurse practitioners need to lead heart failure medication management?
Both professions require specialised postgraduate education in cardiovascular pharmacology, heart failure pathophysiology, and medication optimisation protocols. Many countries offer certificate programmes or fellowships; ongoing continuing education and competency assessment ensure safe practice within defined scope limits.
As healthcare systems worldwide confront rising heart failure prevalence and specialist shortages, the Canadian Journal of Cardiology analysis provides both a clinical and economic blueprint for change. The findings suggest that empowering pharmacists and nurse practitioners to lead medication management—supported by robust training, clear protocols, and physician oversight—represents a high-impact, cost-effective strategy to improve outcomes and strengthen healthcare sustainability. Policymakers in Georgia and other emerging healthcare systems should consider these evidence-based models when designing or expanding their heart failure care infrastructure.
Source: Enlisting pharmacists and nurse practitioners in medication management can fill critical gaps, Medical Xpress (2026)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
